GPR52 agonists represent a novel approach to treat psychotic disorders and improve cognitive functionA.J. Grottick, Niklas Schülert,Holger Rosenbrock, M. Von Heimendahl,Roberto Arban,Scott HobsonEUROPEAN NEUROPSYCHOPHARMACOLOGY(2017)引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要